Inactive Instrument
DIAL BIORFD Share Price Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 22/11/2023 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 13/06/2024 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 31/12/2020 | |
| Chairman | 70 | 31/12/2020 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 31/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| -0.18% | -3.16% | +0.43% | +14.89% | 48.5B | |
| +1.61% | -0.91% | +377.07% | +584.68% | 38.97B | |
| +2.61% | +3.96% | +9.16% | +61.36% | 35.43B | |
| -1.12% | -2.99% | +26.84% | -11.67% | 33.65B | |
| -0.58% | -0.69% | -0.56% | +30.30% | 26.58B | |
| +1.37% | -3.90% | - | - | 16.82B | |
| +0.71% | -0.84% | +72.13% | +116.76% | 15.18B | |
| -2.03% | +0.96% | +13.12% | +14.01% | 13.89B | |
| +0.26% | -0.80% | +19.33% | -32.25% | 12.76B | |
| Average | +0.56% | -0.93% | +64.69% | +97.26% | 26.87B | |
| Weighted average by Cap. | +0.42% | -1.00% | +77.57% | +122.90% |
Employees
4
